Accugenomics
Served as CEO of several pharmaceutical companies including Osmoteca and Endeavor Pharmaceuticals
Served as Executive Vice President at AAI Pharma, a specialty pharma CRO.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Accugenomics
AccuGenomics is a developer of a unique spike-in control technology that dramatically improves the accuracy and performance of clinical sequencing tests for low abundance biomarkers such as circulating tumor DNA (ctDNA) and low titer infectious pathogens such as SARS-CoV-2.